Warning! GuruFocus detected
4 Severe warning signs
with AVE.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Avecho Biotechnology Ltd
ISIN : AU0000047441
Description
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.21 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | -0.37 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -70.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 20.6 | |||||
| 3-Year EPS without NRI Growth Rate | 20.6 | |||||
| 3-Year FCF Growth Rate | 20.6 | |||||
| 3-Year Book Growth Rate | -20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.18 | |||||
| 9-Day RSI | 48.09 | |||||
| 14-Day RSI | 47.61 | |||||
| 3-1 Month Momentum % | 133.33 | |||||
| 6-1 Month Momentum % | 250 | |||||
| 12-1 Month Momentum % | 75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.81 | |||||
| Quick Ratio | 2.73 | |||||
| Cash Ratio | 1.39 | |||||
| Days Inventory | 87.09 | |||||
| Days Sales Outstanding | 157.68 | |||||
| Days Payable | 298.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20 | |||||
| Shareholder Yield % | -2.88 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.37 | |||||
| Operating Margin % | -370.79 | |||||
| Net Margin % | -241.27 | |||||
| FCF Margin % | -306.65 | |||||
| ROE % | -67.55 | |||||
| ROA % | -51.47 | |||||
| ROIC % | -293.94 | |||||
| 3-Year ROIIC % | -34.99 | |||||
| ROC (Joel Greenblatt) % | -1097.26 | |||||
| ROCE % | -65.42 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5 | |||||
| Price-to-Tangible-Book | 5 | |||||
| EV-to-EBIT | -4.75 | |||||
| EV-to-EBITDA | -4.98 | |||||
| EV-to-Revenue | 11.24 | |||||
| EV-to-FCF | -3.67 | |||||
| Earnings Yield (Greenblatt) % | -21.05 | |||||
| FCF Yield % | -25.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Avecho Biotechnology Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 1.294 | ||
| EPS (TTM) (A$) | -0.001 | ||
| Beta | 1.53 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.27 | ||
| Volatility % | 160.2 | ||
| 14-Day RSI | 47.61 | ||
| 14-Day ATR (A$) | 0.000949 | ||
| 20-Day SMA (A$) | 0.005425 | ||
| 12-1 Month Momentum % | 75 | ||
| 52-Week Range (A$) | 0.001 - 0.009 | ||
| Shares Outstanding (Mil) | 3,169.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avecho Biotechnology Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avecho Biotechnology Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avecho Biotechnology Ltd Frequently Asked Questions
What is Avecho Biotechnology Ltd(ASX:AVE)'s stock price today?
The current price of ASX:AVE is A$0.01. The 52 week high of ASX:AVE is A$0.01 and 52 week low is A$0.00.
When is next earnings date of Avecho Biotechnology Ltd(ASX:AVE)?
The next earnings date of Avecho Biotechnology Ltd(ASX:AVE) is .
Does Avecho Biotechnology Ltd(ASX:AVE) pay dividends? If so, how much?
Avecho Biotechnology Ltd(ASX:AVE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers